Jupiter Neurosciences (JUNS) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Jupiter Neurosciences (JUNS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 10K (-50.00%) | 20K | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||
Research And Development | 410K (+925.00%) | 40K (-95.12%) | 820K (+7.89%) | 760K (+61.70%) | 470K (+135.00%) | 200K (+122.22%) | 90K (-10.00%) | 100K (0.00%) | 100K (-86.11%) | 720K (+200.00%) | 240K | - | - |
Selling General And Administrative | 1.57M (-43.53%) | 2.78M (+87.84%) | 1.48M (-1.99%) | 1.51M (+41.12%) | 1.07M (-15.75%) | 1.27M (+217.50%) | 400K (-13.04%) | 460K (-2.13%) | 470K (-72.51%) | 1.71M (+42.50%) | 1.20M | - | - |
Operating Expenses | 1.98M (-30.04%) | 2.83M (+23.04%) | 2.30M (+1.77%) | 2.26M (+46.75%) | 1.54M (+4.76%) | 1.47M (+200.00%) | 490K (-12.50%) | 560K (-1.75%) | 570K (-76.54%) | 2.43M (+68.75%) | 1.44M | - | - |
Operating Income | |||||||||||||
Operating Income | -1.96M (-30.25%) | -2.81M (+22.17%) | -2.30M (+1.77%) | -2.26M (+46.75%) | -1.54M (+4.76%) | -1.47M (+200.00%) | -490.00K (-12.50%) | -560.00K (-1.75%) | -570.00K (-76.54%) | -2.43M (+68.75%) | -1.44M | - | - |
Ebit | -1.96M (-30.25%) | -2.81M (+22.17%) | -2.30M (+1.77%) | -2.26M (+46.75%) | -1.54M (+4.76%) | -1.47M (+200.00%) | -490.00K (-12.50%) | -560.00K (-1.75%) | -570.00K | 150K | -1.44M (+73.49%) | -830.00K (-52.57%) | -1.75M |
EBITDA | -1.94M (-22.71%) | -2.51M (+9.61%) | -2.29M (+1.78%) | -2.25M (+47.06%) | -1.53M (+1.32%) | -1.51M (+214.58%) | -480.00K | 370K | -570.00K (+96.55%) | -290.00K (-82.84%) | -1.69M (+103.61%) | -830.00K (-52.57%) | -1.75M |
Other Income / Expenses | |||||||||||||
Interest Income | 20K | -30.00K | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - |
Interest Expense | 120K (+100.00%) | 60K | - | - | - | 20K (-81.82%) | 110K (+83.33%) | 60K (-14.29%) | 70K (-50.00%) | 140K (+75.00%) | 80K | - | - |
Net Interest Income | 20K | -30.00K | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - |
Other Non Operating Income | -100.00K | 260K (+2500.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-98.46%) | 650K | -100.00K | 870K | -60.00K (-93.41%) | -910.00K (+175.76%) | -330.00K | - | - |
Net Income | |||||||||||||
Net Income From Continuing Operations | -2.06M (-20.16%) | -2.58M (+12.66%) | -2.29M (+1.78%) | -2.25M (+47.06%) | -1.53M (0.00%) | -1.53M (+159.32%) | -590.00K | 310K | -630.00K (+46.51%) | -430.00K (-75.71%) | -1.77M (+113.25%) | -830.00K (-52.57%) | -1.75M |
Net Income | -2.06M (-20.16%) | -2.58M (+12.66%) | -2.29M (+1.78%) | -2.25M (+47.06%) | -1.53M (0.00%) | -1.53M (+159.32%) | -590.00K | 310K | -630.00K (+46.51%) | -430.00K (-75.71%) | -1.77M (+113.25%) | -830.00K (-52.57%) | -1.75M |